Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579800 · ClinicalTrials.gov registry record · NA
Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT00579800: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579800 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579800, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate new computer software on breast magnetic resonance imaging (MRI). The information from this study may help doctors and scientists develop better ways to find breast cancer, and may help future patents with cancer.
Interventions
- PROCEDURE new software sequences, FIESTA and Vibrant-DE and IDEAL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2007-07 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579800
The ClinicalTrials.gov registry entry for NCT00579800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which new software sequences, FIESTA and Vibrant-DE and IDEAL is the first listed.
NCT00579800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579800 about?
NCT00579800 is a clinical study titled "Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation". The purpose of this study is to evaluate new computer software on breast magnetic resonance imaging (MRI). The information from this study may help doctors and scientists develop better ways to find breast cancer, and may help future patents with cancer.
What is the current status of trial NCT00579800?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2007-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00579800?
The interventions under investigation include: new software sequences, FIESTA and Vibrant-DE and IDEAL (PROCEDURE).
Who is sponsoring clinical trial NCT00579800?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.